DETAIL
■この商品は「予約販売商品」です
・この商品はコンビニ払いがご利用できません。
・Erler-Zimmer GmbH & Co.KG(ドイツ)で受注生産のため、納期は4〜6カ月かかります。
・ご注文いただいた後、入荷時期が確定いたしましたら、正式にメールにてご連絡申し上げます。
本製品の説明は英語のみです。
Product information "Tuberculosis"
Clinical History
A 37-year old female presents with increasing thoracic back pain. She has a history of untreated human immunodeficiency virus (HIV) infection and pulmonary tuberculosis. History revealed ongoing low-grade fevers, chills and weight loss. Examination revealed a cachexic patient with tender thoracic vertebrae at multiple levels. Blood test showed an elevated serum calcium and erythrocyte sedimentation rate. X-ray of her spine showed lytic areas in the thoracic vertebrae. During her hospital admission, she developed urosepsis and died.
Pathology
The specimen is a portion of the patient’s thoracic vertebral column that has been sawn longitudinally and mounted to display the cut surface of 7 thoracic vertebrae. In all vertebrae, there are osteolytic areas, varying from 1 to 12 mm in diameter, which contain caseous degenerative material* (mostly now lost) and are surrounded by a thin zone of dense bone. The tuberculous inflammatory process has extended into one of the intervertebral discs, and has also spread outside the vertebral bodies to form collections of caseous material beneath the anterior longitudinal ligament. This is an example of tuberculous mycobacterial osteomyelitis of the vertebral column with paravertebral extension, also known as Pott’s Disease.
Further Information
Tuberculosis (TB) is a chronic pulmonary and systemic infectious disease caused by Mycobacteria tuberculosis. Transmission most commonly occurs via inhalation of aerosolized droplets of M. tuberculosis. Risk factors for contracting TB include being an inhabitant of a ‘developing’ country where the disease may be endemic, immunosuppression (e.g. HIV, steroid use, anti-TNF use and diabetes), chronic lung disease (e.g. silicosis), alcoholism, and generalized malnutrition.
After initial pulmonary infection of M. tuberculosis clinical manifestation varies. In 90% of individuals with an intact immune system, they enter an asymptomatic latent infection phase. This latent TB may reactivate at any time in the patient‘s life. In the other 10% of patients, especially in the immunocompromised population, they develop primary disease, which is immediate active TB infection. Manifestations of primary TB include pulmonary infection symptoms (e.g. consolidation, effusion and hilar adenopathy) and extra pulmonary symptoms - lymphadenopathy, meningitis and disseminated miliary TB. Secondary tuberculosis occurs when there is reactivation of a previous latent TB infection. Around 10% of latent TB will reactivate usually during periods of weakened host immunity. Typical symptoms of reactivation are cough, haemoptysis, low grade fever, night sweats and weight loss.
Osseous infection occurs 1-3% of patients with TB infection. There is a higher incidence of developing bone disease in patients from developing countries and immunocompromised patients. The TB usually spreads haematogenously from the site of active disease. Pott’s disease accounts for 40% of TB bone infections. The infection is destructive eroding vertebral discs and vertebrae leading to compression fractures, which may cause symptoms of cord or nerve root compression. Symptoms include pain at the site of disease, fevers, chills, weight loss, symptoms of compression and spinal deformities, such as kyphosis and scoliosis.
TB diagnosis is usually made with a clinical history and chest x-ray and multiple sputum cultures. Mantoux skin tuberculin test and serum interferon gamma release assay may also be used to help screen for infection. Biopsies may be taken of suspected infection site for culture to assist diagnosis.
Treatment involves prolonged courses of multiple antibiotics, which depend on the antibiotic resistance of the infecting mycobacterium species.
* Caseous degeneration or necrosis is a unique form of cell death in which the tissue maintains a cheese-like appearance.
●京都科学品番:EZ-313 ●メーカー品番:MP2111
Erler-Zimmer GmbH & Co.KG の模型製品は、
日本国内において株式会社京都科学の独占販売製品です。